drugset / Trial / NCT00759408

The Role of Endothelin in Pulmonary Hypertension

NCT00759408

Phase 2 Completed 38 enrolled Brigham and Women's Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is is to determine the effect, on the lung circulation, of BQ-123, an investigational compound which is not approved by the FDA.

Timeline

Start
1999-02
Primary completion
2010-10
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject BQ-123 Peptide